Search

everythinglearnresearchcommunity

for

Search:↓

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

Hair loss in Egyptian patients without scarring was studied, and it was found to significantly affect their quality of life.

Bimatoprost is safe and effective for treating eyelash loss caused by chemotherapy.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

New evaluation tools are needed for better surgical training in dermatology residency programs.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

SVF-PRP therapy effectively reverses hair loss effects.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Early treatment helps stop hair loss in women of color.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Hair transplants are effective for male and female pattern baldness, have evolved in technique, and require careful planning for natural results and managing complications.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

The conclusion is that using the 5W1H method can improve diagnosis and management of childhood hair-pulling disorder.